COURT-RULING ·Filed Aug 12, 2026
Court ruling (district)
Actionable Insight • Neutral
This is a routine procedural filing granting pro hac vice admission for defense counsel in an ongoing patent dispute between Medtronic and Recor Medical. No substantive ruling was issued — no impact on Medtronic's stock or operations.
Latest settled — T+20d
MDT ▲ +0.95% at T+20d
NEUTRAL call ✓ call won +0.95% · α vs SPY +2.85% · entry $90.76 → $91.62
Latest observation: T+33 -9.81% FF3 residual α
T+1d
-0.20%
call -0.20% · α -0.90%
$90.58
settled 7w ago
T+5d
+3.71%
call +3.71% · α +4.16%
$94.13
settled 6w ago
T+20d
+0.95%
call +0.95% · α +2.85%
$91.62
settled 23d ago
T+60d
—
call — · α —
—
in 5w
Price Chart
Loading chart...
Executive Summary
The court granted a routine pro hac vice application for an attorney to represent Recor Medical in a patent case against Medtronic. This is a purely procedural order with no substantive impact on the merits of the case or Medtronic's business.
Court Ruling Details
Ruling Date
Aug 12, 2026
Court
United States District Court for the Northern District of California
Court Level
District
Case Type
other
Ruling Type
other
Will It Be Appealed?
N/A (final)
Precedent Risk
LOW
Key Facts
- Court granted pro hac vice admission for defense counsel in Medtronic v. Recor Medical patent case
- No substantive ruling on the merits was issued
- This is a routine procedural order with no financial or operational impact on Medtronic
Financial Impact
None — purely procedural ruling
Risk Factors
- No material risks identified from this filing
Market Snapshot
Exchange
NYSE
Sector
Electromedical & Electrotherapeutic Apparatus
Analyst Consensus
65% bullish (34 analysts)
Investment Themes
Healthcare & Medical Devices
Documents Analyzed
This report is based on 1 court opinion from CourtListener.
| Document | Accession Number |
|---|---|
| COURT-RULING Data (Synthetic) | court-b84fcfa492-MDT |
21 reports for MDT
100% Hit rate best @ T+60▲ +15.30%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 16, 2026 16d ago | Press Release | $92.60 $89.30 | ▼ −3.56% | ▼ −6.13% | $87.42 (−5.60%) |
Sep 15, 2026 16d ago | 425 | $92.60 $89.30 | ▼ −3.56% | ▼ −6.13% | $87.42 (−5.60%) |
Sep 14, 2026 17d ago | 425 | $93.75 $90.77 | ▼ −3.18% | ▼ −5.29% | $87.42 (−6.76%) |
Sep 14, 2026 18d ago | 425 | $93.80 $91.75 | ▼ −2.19% | ▼ −2.29% | $87.42 (−6.81%) |
Sep 14, 2026 18d ago | 425 | $93.80 $91.75 | ▼ −2.19% | ▼ −2.29% | $87.42 (−6.81%) |
Sep 1, 2026 4w ago | Press Release | $92.03 $91.89 | ▼ −0.15% | ▼ −0.23% | $87.42 (−5.01%) |
Sep 1, 2026 4w ago | 8-K | $92.04 $91.89 | ▼ −0.16% | ▼ −0.24% | $87.42 (−5.02%) |
Sep 1, 2026 4w ago | Press Release | $92.04 $91.89 | ▼ −0.16% | ▼ −0.24% | $87.42 (−5.02%) |
Aug 31, 2026 4w ago | Court Ruling | $90.65 $92.39 | ▲ +1.92% | ▲ +2.06% | $87.42 (−3.57%) |
Aug 20, 2026 6w ago | Press Release | $93.35 $91.15 | ▼ −2.36% | ▼ −2.83% | $87.42 (−6.36%) |
Showing 10 of 21
US Market Status
Market Open — Closes in 4h 34m
Subscribe to SecBot
Get Real-Time Court Ruling Intelligence
Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more — parsed and scored by AI.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access